DaltonTx

Dalton Therapeutics (DaltonTx) is a Toronto-based biotechnology company focused on the discovery of novel small molecule drugs for challenging therapeutic targets. The company utilizes a proprietary medicinal chemistry-driven platform to address "undruggable" proteins, particularly those involved in protein-protein interactions. DaltonTx aims to streamline the hit-to-lead and lead optimization phases of drug discovery to create a robust pipeline of candidates for oncology and immunology. The firm operates with a lean, expert-led model, leveraging deep expertise in synthetic and medicinal chemistry to advance its internal programs toward clinical readiness. By integrating discovery efforts with established manufacturing capabilities, DaltonTx accelerates the development of high-quality therapeutic leads.